Richard B. Moss, M.D., Professor Emeritus at Stanford University School of Medicine, works in the Department of Pediatrics’ Center for Excellence in pulmonary biology. He is former chief of the pediatric pulmonary and allergy divisions, and former allergy-immunology and pulmonary fellowship training programs director at Lucile Packard Children’s Hospital Stanford. He was educated and trained at Columbia (for his B.A.), SUNY Downstate (for his M.D.), Children’s Memorial Hospital of Northwestern University (for his pediatric residency) and Stanford University Medical Center (for allergy-immunology and pulmonology fellowships). He was director of the Cystic Fibrosis Center at Stanford from 1991 to 2009 and a principal investigator for the Foundation’s Therapeutics Development Network (TDN), where he also served as the inaugural chair of the TDN Protocol Review Committee. He joined Cystic Fibrosis Research, Inc.’s board of directors in 2015. He has been a member of Stanford’s Child Health Research Institute and has served on Stanford’s Pediatric Mentoring Program for trainees and junior faculty, the Executive Committee of Spectrum Child Health and Stanford’s Institutional Review Board. Dr. Moss has reviewed and consulted for the National Institutes of Health and Cystic Fibrosis Foundation; national and international foundations in the U.S., Canada, UK, Germany, Italy and elsewhere; and many peer-review bioscience journals and biopharmaceutical companies. He has published over 250 research papers and is a frequent speaker at national and international medical conferences. His research interests have included pathogenesis, outcome measures, and treatment of chronic airway diseases of childhood such as asthma, CF and chronic lung disease of infancy, with an emphasis on mechanisms of pulmonary immunity, inflammation and allergy. Recent work has focused on allergic fungal lung disease and clinical testing of novel CF diagnostic and outcome tests and treatments.